ANUHPHR vs FISCHER: Stock Comparison
FISCHER MEDICAL VENTURE L is the larger company by market capitalisation. ANUH PHARMA shows a lower P/E, a higher ROE and a higher dividend yield, while FISCHER MEDICAL VENTURE L shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ANUHPHR leads 7; FISCHER leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ANUHPHR | FISCHER |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Medical Equipment & Supplies |
Price
| Metric | ANUHPHR | FISCHER |
|---|---|---|
| Live Price | ₹81.55 | ₹24.3 |
| Day Change | -0.74% | -2.88% |
| Volume | 59,502 | 5.81 L |
| 52-Week High | ₹99.5 | ₹99 |
| 52-Week Low | ₹67 | ₹21.78 |
| Distance from 52W High | -18.04% | -75.45% |
Valuation
| Metric | ANUHPHR | FISCHER |
|---|---|---|
| Market Cap | ₹815 Cr | ₹1,694 Cr |
| P/E Ratio | 0x | 52.72x |
| P/B Ratio | 0x | 4.13x |
| EPS | ₹1.12 | ₹0.06 |
| Book Value | ₹35.14 | ₹5.88 |
| Dividend Yield | 1.85% | 0.21% |
Growth
| Metric | ANUHPHR | FISCHER |
|---|---|---|
| Revenue Growth (TTM YoY) | 2% | 98.7% |
| EPS Growth (TTM YoY) | -6% | 0% |
| Qtr Sales Growth | -4.42% | 0% |
| Qtr Profit Growth | -1.85% | 0% |
Profitability & Leverage
| Metric | ANUHPHR | FISCHER |
|---|---|---|
| ROE | 11.65% | 8.05% |
| ROCE | 11.96% | 7.89% |
| Net Margin | 5.32% | 6.79% |
| Operating Margin | 7.09% | 16.99% |
| Debt to Equity | 0x | 0.19x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | ANUHPHR | FISCHER |
|---|---|---|
| Promoter Holding | 71.78% | 12.31% |
| FII Holding | 0.11%▲ 0.1 pp | 6.71%▲ 1.14 pp |
| DII Holding | 0% | 1.26% |
| Public Holding | 28.09%▼ 0.1 pp | 28.94%▼ 1.15 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ANUH PHARMA and FISCHER MEDICAL VENTURE L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.